Pulseless ventricular tachycardia MRI: Difference between revisions
Jump to navigation
Jump to search
Aisha Adigun (talk | contribs) No edit summary |
Aisha Adigun (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
There are no specific [[MRI]] findings associated with [[pulseless ventricular tachycardia]]. However, a cardiac MRI may be helpful when [[structural heart disease]] is implicated as an etiology and the assessment provided by echocardiography is not satisfactory. A [[cardiac MRI]] | There are no specific [[MRI]] findings associated with [[pulseless ventricular tachycardia]]. However, a cardiac MRI may be helpful when [[structural heart disease]] is implicated as an etiology and the assessment provided by echocardiography is not satisfactory. A [[cardiac MRI]]<ref name="pmid16949478">{{cite journal |vauthors=Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL |title=ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) |journal=J. Am. Coll. Cardiol. |volume=48 |issue=5 |pages=e247–346 |date=September 2006 |pmid=16949478 |doi=10.1016/j.jacc.2006.07.010 |url=}}</ref> is particularly helpful in the evaluation of structural heart disease i.e [[arrhythmogenic right ventricular cardiomyopathy]] as well it's infiltrative diseases such as [[sarcoidosis]].<ref name="urlwww.cancertherapyadvisor.com">{{cite web |url=https://www.cancertherapyadvisor.com/home/decision-support-in-medicine/hospital-medicine/ventricular-tachycardia/ |title=www.cancertherapyadvisor.com |format= |work= |accessdate=}}</ref> | ||
==MRI== | ==MRI== | ||
Revision as of 08:32, 9 July 2020
|
Pulseless ventricular tachycardia Microchapters |
|
Differentiating Pulseless ventricular tachycardia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pulseless ventricular tachycardia MRI On the Web |
|
American Roentgen Ray Society Images of Pulseless ventricular tachycardia MRI |
|
Risk calculators and risk factors for Pulseless ventricular tachycardia MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]
Overview
There are no specific MRI findings associated with pulseless ventricular tachycardia. However, a cardiac MRI may be helpful when structural heart disease is implicated as an etiology and the assessment provided by echocardiography is not satisfactory. A cardiac MRI[1] is particularly helpful in the evaluation of structural heart disease i.e arrhythmogenic right ventricular cardiomyopathy as well it's infiltrative diseases such as sarcoidosis.[2]
MRI
- There are no specific MRI findings associated with pulseless ventricular tachycardia. However, a cardiac MRI may be helpful when structural heart disease is implicated as an etiology and the assessment provided by echocardiography is not satisfactory.
- A cardiac MRIef name="pmid16949478">Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL (September 2006). "ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)". J. Am. Coll. Cardiol. 48 (5): e247–346. doi:10.1016/j.jacc.2006.07.010. PMID 16949478.</ref> is particularly helpful in the evaluation of;
- Structural heart disease i.e arrhythmogenic right ventricular cardiomyopathy and
- Infiltrative diseases such as sarcoidosis.[2]
References
- ↑ Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL (September 2006). "ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)". J. Am. Coll. Cardiol. 48 (5): e247–346. doi:10.1016/j.jacc.2006.07.010. PMID 16949478.
- ↑ 2.0 2.1 "www.cancertherapyadvisor.com".